NSE equity
Unclassified
Equity
ISIN INE351Y01019

BETABeta Drugs Limited

Latest close

1817.4

-1.15%

Price

Price history

13/10/2026 to 13/11/2026

O 1,874.90 H 1,890.70 L 1,810.50

1,977.901,664.7013/10/202613/11/2026

Performance

Day low

1,810.50

Day high

1,890.70

52 week low

990.10

52 week high

2,807.90

Open price

1,874.90

Previous close

1,838.50

Volume

11,610

1M

-11.99%

1Y

+12.39%

30D avg vol

61,962

Fundamentals

Sep-26 · 30/09/2026

SectorBroad business classification for this issuer.Unclassified
IndustryNarrower business classification inside the sector.Equity
52W HighHighest traded price over the latest 52-week window.2,807.90
52W LowLowest traded price over the latest 52-week window.990.10
Market capCompany value from the latest fundamentals row, shown in crore or lakh-crore.₹2,021.18 Cr
P/EPrice-to-earnings ratio: market price divided by earnings per share.37.89
P/BPrice-to-book ratio: market price divided by book value per share.4.21
EPSEarnings per share from the latest fundamentals.₹16.59
RevenueRevenue reported in the latest fundamentals period.₹137.49 Cr
PATProfit after tax reported in the latest fundamentals period.₹19.28 Cr

Financials

Financial performance

RevenuePAT
Revenue growth-32.5%
Profit growth-19.4%

Membership

Index exposure

No current index membership found for this stock.

Sector

Same-sector stocks

No same-sector stocks with price history found.

Insider trades

Disclosures by promoters and officers

DateSidePersonQtyCategory
13/11/2025SELLNeeraj Batra1,85,115Promoters

Other filings

Misc disclosures

DateTypeTitle
22/10/2026ResultsSep-26 results
20/07/2026ResultsJun-26 results
14/05/2026ResultsFY25-26 results
14/05/2026ResultsMar-26 results
14/02/2026ResultsDec-25 results
06/11/2025ResultsSep-25 results
15/05/2025ResultsFY24-25 results
15/05/2025ResultsMar-25 results